IBISWorld Platform
Answer any industry question in minutes with our entire database at your fingertips.
4DMedical Limited
4DMedical is a Public Company that generates the majority of its income from the Diagnostic Imaging Services industry. In 2025 the company generated total revenue of $16,828,000 including sales and other revenue. In 2025 4DMedical had 124 employees including employees from all subsidiaries under the company's control. The Chief Executive of 4DMedical is Mr Andreas Fouras whose official title is Managing Director & Chief Executive Officer. The Chairman of 4DMedical is Ms Lil Bianchi whose official title is Non-Executive Chair. 4DMedical Limited is engaged in the researching of medical technology, as well as the development of a respiratory imaging solution based on converting x ray images using proprietary software models. The company provides the following products: Production of medical reports specialising in the detection of lung disease, utilising existing hospital equipment through their software as a service product XV technology. The AccuVent 200, a small animal ventilator aimed at preclinical researchers. The Permetium products, which the company describes as a commercially dedicated preclinical imaging system of the lungs.
Access this data your way
The 4DMedical Limited Industry analysis is available in multiple formats to fit seamlessly into your workflow.
API Data Delivery
Feed trusted, human-driven industry intelligence straight into your platform.
Integrations
Streamline your workflow with IBISWorld’s intelligence built into your toolkit.
What's included in this industry analysis
IBISWorld's research coverage on the 4DMedical Limited includes market sizing, forecasting, data and analysis. The most recent publication will be as current as of March 2026.
Company Details
What’s this enterprise profile about?
4DMedical Limited, trading as 4DMedical, operates under the ABN 31 161 684 831 and was incorporated on 17 December 2012. 4DMedical Limited trades on the Australian Securities Exchange under the ticker code ASX:4DX. 4DMedical Limited primarily operates in the Diagnostic Imaging Services industry in Australia.
Key Personnel
What’s included in the Key Personnel chapter?
The Key Personnel chapter outlines the principal leadership positions within 4DMedical Limited, including the Chairman, Board members, Chief Executive Officer, and other key management personnel. It provides an overview of the company’s governance and executive structure, along with a breakdown of gender diversity across leadership roles, offering insight into the composition of the organisation’s senior team.
Financials
What’s included in the Financials chapter?
The Financials chapter presents 4DMedical Limited’s historical financial performance, including detailed profit and loss statements outlining sales revenue, cost of sales, and profitability. It also incorporates balance sheet data, providing a breakdown of assets and liabilities, as well as additional financial metrics such as the number of shares on issue. Together, these disclosures offer a comprehensive view of the company’s financial position and performance over time.
Growth & Ratios
What’s included in the Growth & Rations chapter?
The Growth & Ratios chapter provides historical data on key financial performance indicators, enabling an assessment of the company’s operational efficiency, profitability, and financial structure over time. Metrics covered include return on equity, return on assets, profit margins, revenue per employee, as well as gearing and leverage ratios, offering a comprehensive view of performance trends and capital management.
Operating Segments
What’s included in the Operating Segments chapter?
The Operating Segments chapter provides an overview of the revenue composition and asset allocation across the various industries in which 4DMedical Limited operates. It offers insights into how the company’s financial performance is distributed among its core business segments, highlighting the relative contribution of each industry to total revenue.
Competitor Benchmarking
What’s included in the Competitor Benchmarking chapter?
The Competitor Benchmarking chapter includes a comparative assessment of 4DMedical Limited’s key financial, growth, and valuation ratios against industry averages to evaluate its competitive position. It analyses valuation metrics such as price-to-earnings, price-to-book, enterprise value to EBITDA, and enterprise value to sales, alongside core financial indicators including liquidity ratios and profitability measures.
Shareholders
What’s included in the Shareholders chapter?
The Shareholders chapter provides a breakdown of the ownership structure of 4DMedical Limited, identifying key shareholders and outlining their respective ownership interests. This section offers insight into the concentration of shareholdings, the presence of institutional or strategic investors, and the overall distribution of equity within the company.
Subsidiaries
What’s included in the Subsidiaries chapter?
The Subsidiaries chapter provides an overview of the companies and business entities that are wholly or partially owned by 4DMedical Limited. It outlines the ownership structure of each subsidiary, offering insight into the broader corporate group and how these entities contribute to the company’s overall activities and performance.
History
What’s included in the History chapter?
The History chapter presents a overview of 4DMedical Limited’s development, highlighting key milestones and significant corporate events since its incorporation. It includes the company’s incorporation date and outlines major strategic, operational, and structural developments, providing context for its evolution and current market position.
Trusted by industry professionals
More than 6,000 businesses use IBISWorld to shape local and global economies
We were able to supplement our reports with IBISWorld’s information from both a qualitative and quantitative standpoint. All of our reporting now features some level of IBISWorld integration.
IBISWorld delivers the crisp business knowledge we need to drive our business. Whether it be serving up our major clients, winning new business or educating on industry issues, IBISWorld brings real value.
IBISWorld has revolutionised business information — which has proved commercially invaluable to exporters, investors and public policy professionals in Australia and overseas.
When you’re able to speak to clients and be knowledgeable about what they do and the state that they operate in, they’re going to trust you a lot more.
Frequently Asked Questions
What is 4DMedical Limited?
4DMedical Limited is engaged in the researching of medical technology, as well as the development of a respiratory imaging solution based on converting x ray images using proprietary software models. The company provides the following products: Production of medical reports specialising in the detection of lung disease, utilising existing hospital equipment through their software as a service product XV technology. The AccuVent 200, a small animal ventilator aimed at preclinical researchers. The Permetium products, which the company describes as a commercially dedicated preclinical imaging system of the lungs.
What industry does 4DMedical Limited operate in?
4DMedical Limited, trading as 4DMedical, is a Public Company that generates the majority of its income from the Diagnostic Imaging Services industry in Australia.
Where is 4DMedical Limited located?
Murray Cod Australia Limited company is based at 700 Swanston Street, Carlton, Victoria, Australia.
Who is the CEO of 4DMedical Limited?
The Managing Director & Chief Executive Officer of 4DMedical Limited is Lil Bianchi and the Managing Director & Chief Executive Officer is Andreas Fouras.
What was 4DMedical Limited’s revenue in 2025?
In 2025, 4DMedical Limited generated total revenue of approximately $16.8 million.
Cut through the noise with intelligence you can trust
